UCSF home page UCSF home page About UCSF UCSF Medical Center School of Medicine Department of Urology
UCSF navigation bar
 department navigation bar
Image denoting funding page  

Research Awards and Grants

Active

R01 DK073449-01 (Baskin)
7/15/2007-6/30/2012
NIH/NIDDK
Genes Inducing Bladder Smooth Muscle Formation
Goals: The goal of this proposal is to investigate the mechanism of bladder smooth muscle differentiation
Role: Principal Investigator

K12 DK083021 (Baskin)
9/30/2008-7/31/2013
UCSF KURe Career Development Program
Goals: The major goal of this proposal is to recruit a superb and diverse group of health science scholars early in their academic careers to enable them to conduct important research and to facilitate their long-term retention for significant contributions as researchers and leaders with a focus in resarch of benign urologic diseases.
Role: Principal Investigator

R01 (Baskin)
7/1/2011-6/30/2016
NIH/NIDDK
Hypospdias Differentiation and Endocrine Disruptors
Goals: The major goal of this proposal is to confirm a new paradigm of sexual differentiation that states that the hormone estrogen in addition to the classic male hormone testosterone are critical for normal masculine and feminine development of the penis and clitoris.
Role: Principal Investigator

NSF IOS 0920793 (Glickman)
1/1/2009-12/31/2013
NSF/Subcontract
NSF/UC Berkeley Hyena Project
Goals: The major goal of this proposal is to study the role of estrogens and androgens in normal masculine and feminine development of the external genitalia of the spotted hyena and the mouse.
Role: Principal Investigator UCSF site

R01 ES16863-01 (Swan)
7/1/2009-6/30/2014
NIH/Subcontract
The Infant Development and Environment Study (TIDES)
Goals: The major goal of this proposal is to confirm the hypothesis that male anogenital distance (AGD) at birth is inversely related to the concentration of one or more metabolites of DEHP and BDP, separately or in combination, in first trimester urine samples; to develop a simple, reproducible method for measuring AGD in a clinical setting, and determine standardized percentiles for these in male newborns; and test the hypothesis that a shortened AGD is a long-lasting marker of altered genital tract development in males, by comparing AGD percentiles at birth, 6, and 12 months.
Role: Principal Investigator UCSF site

U10 HD41669 (Harrison)
3/1/2002-2/29/2012
COOP
Multicenter Trial of Fetal Myelomeningocele Repair
Goals: The main goal of this proposal is to determine whether intrauterine repair of fetal myelomeningocele at 190 to 256 weeks gestation improves outcome, as measured by 1) death or the need for ventricular decompressive shunting by one year of life, and 2) a composite neurologic function score at 30 months corrected age. Secondary goal is to determine the effect on bladder function.
Role: Co-Investigator UCSF site


 

 

 




return to top